Pfizer vs AstraZeneca: let battle commence
Pierre Meulien, Executive Director of the Innovative Medicines Initiative (IMI) in Europe, outlines the value of…
This week the Korean Ministry of Food and Drug Safety announced that as of 12th March 2019 a revised narcotics bill…
Turkey – home to an 80 million-strong population, a substantial pharmaceuticals market and a universal healthcare…